Coronavirus (COVID-19) Current Therapy Global Market Report 2023

Feb 2023| TBR1058F| TBRC (Publisher)

Sample Report

Report Highlights

Including: 1) By Drug Type: Remdesivir; Hydroxychloroquine; Ritonavir; Lopinavir; Interferon Beta
2) By Route Of Administration: Oral; Intravenous
3) By End User: Hospitals; Clinics; Research Institutes
Covering: Moderna Therapeutics; Novavax; Bravovax; Ascletis Pharma; Altimmune

Coronavirus (COVID-19) Current Therapy Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on coronavirus (covid-19) current therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
Assess the Russia – Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Description:
Where is the largest and fastest growing market for coronavirus (covid-19) current therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The coronavirus (covid-19) current therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

Report Synopsis

Report Metrics	Details
Base year considered	2022
Forecast period considered	2022-2032
Units considered	$ Billion
Segments covered	By Drug Type, By Route Of Administration, By End User
Industry covered	Pharmaceuticals
Regions covered	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Countries covered	Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA
Companies studied	Moderna Therapeutics Takis Biotech Bravovax Novavax Ascletis Pharma Altimmune Clover Biopharmaceuticals Inovio Pharmaceuticals Inc. Biocryst Pharma Gilead Sciences Regeneron Pharmaceuticals Applied DNA Sciences Inc. Codagenix GeoVax Labs Inc. Vaxil Bio Ltd. Evvivax Zydus Cadila MIGAL Galilee Research Institute Generex Biotechnology Corporation Janssen Pharmaceuticals Greffex Inc. CanSino Biologics Inc. ExpreS2ion Biotechnologies ApS iBio Pharma Inc. Tonix Pharmaceuticals Curevac ImmunoPrecise AbbVie AbCellera/Eli Lilly Stemirna Therapeutics

Scope

Markets Covered:

By Drug Type: Remdesivir; Hydroxychloroquine; Ritonavir; Lopinavir; Interferon Beta; Other Drug Type
By Route Of Administration: Oral; Intravenous
By End User: Hospitals; Clinics; Research Institutes; Other End Users

Companies Mentioned: Moderna Therapeutics; Novavax; Bravovax; Ascletis Pharma; Altimmune

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Table 1 : Global Historic Market Growth, 2017-2022, $ Billion
Table 2 : Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
Table 3 : Global Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 4 : Global Coronavirus (COVID-19) Current Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 5 : Global Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 6 : Global Coronavirus (COVID-19) Current Therapy Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 7 : Global Coronavirus (COVID-19) Current Therapy Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 8 : Asia-Pacific, Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 9 : Asia-Pacific, Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 10 : China, Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 11 : China, Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 12 : India, Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 13 : India, Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 14 : Japan, Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 15 : Japan, Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 16 : Australia, Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 17 : Australia, Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 18 : Indonesia, Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 19 : Indonesia, Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 20 : South Korea, Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 21 : South Korea, Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 22 : Western Europe, Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 23 : Western Europe, Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 24 : UK, Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 25 : UK, Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 26 : Germany, Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 27 : Germany, Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 28 : France, Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 29 : France, Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 30 : Eastern Europe, Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 31 : Eastern Europe, Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 32 : Russia, Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 33 : Russia, Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 34 : North America, Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 35 : North America, Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 36 : USA, Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 37 : USA, Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 38 : South America, Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 39 : South America, Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 40 : Brazil, Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 41 : Brazil, Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 42 : Middle East, Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 43 : Middle East, Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 44 : Africa, Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 45 : Africa, Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Table 46 : Moderna Therapeutics Financial Performance
Table 47 : Novavax Financial Performance
Table 48 : Bravovax Financial Performance
Table 49 : Ascletis Pharma Financial Performance
Table 50 : Altimmune Financial Performance

Figure 1 : Global Historic Market Growth, 2017-2022, $ Billion
Figure 2 : Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
Figure 3 : Global Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 4 : Global Coronavirus (COVID-19) Current Therapy Market, Segmentation By Route Of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 5 : Global Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 6 : Global Coronavirus (COVID-19) Current Therapy Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 7 : Global Coronavirus (COVID-19) Current Therapy Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 8 : Asia-Pacific, Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 9 : Asia-Pacific, Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 10 : China, Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 11 : China, Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 12 : India, Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 13 : India, Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 14 : Japan, Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 15 : Japan, Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 16 : Australia, Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 17 : Australia, Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 18 : Indonesia, Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 19 : Indonesia, Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 20 : South Korea, Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 21 : South Korea, Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 22 : Western Europe, Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 23 : Western Europe, Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 24 : UK, Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 25 : UK, Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 26 : Germany, Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 27 : Germany, Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 28 : France, Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 29 : France, Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 30 : Eastern Europe, Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 31 : Eastern Europe, Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 32 : Russia, Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 33 : Russia, Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 34 : North America, Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 35 : North America, Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 36 : USA, Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 37 : USA, Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 38 : South America, Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 39 : South America, Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 40 : Brazil, Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 41 : Brazil, Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 42 : Middle East, Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 43 : Middle East, Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 44 : Africa, Coronavirus (COVID-19) Current Therapy Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 45 : Africa, Coronavirus (COVID-19) Current Therapy Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Figure 46 : Moderna Therapeutics Financial Performance
Figure 47 : Novavax Financial Performance
Figure 48 : Bravovax Financial Performance
Figure 49 : Ascletis Pharma Financial Performance
Figure 50 : Altimmune Financial Performance

The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Similar Reports from TBRC (Publisher)

Coronavirus (COVID-19) Current Therapy Global Market Opportunities And Strategies To 2031: COVID-19 Impact and Recovery

Published Date - Jul 2022
Report Code - TBR1058E

Including: 1) By Drug Type: Antiviral; Monoclonal Antibodies; Corticosteroid; Supplements; Antimalarial; Interferons And Interleukin Inhibitors; Other Anti-Infective Drugs; Others
2) By End-User: Hospitals; Clinics; Home Care; Others
Covering: Gilead Sciences, Inc.; F. Hoffmann-La Roche AG; Ipca Laboratories Limited; Zydus Cadila; Regeneron Pharmaceuticals, Inc.

Coronavirus (COVID-19) Current Therapy Global Market Opportunities And Strategies To 2031: COVID-19 Impact and Recovery from The ...

Coronavirus (COVID-19) Current Therapy Global Market Opportunities And Strategies To 2030: COVID-19 Growth And Change

Published Date - Jun 2022
Report Code - TBR1058D

Including: 1) By Drug Type: Antiviral; Monoclonal Antibodies; Corticosteroid; Supplements; Antimalarial; Interferons And Interleukin Inhibitors; Other
2) By End User: Hospitals; Clinics; Home Care; Others
Covering: Gilead Sciences, Inc.; F. Hoffmann-La Roche AG; Ipca Laboratories Limited; Zydus Cadila; Regeneron Pharmaceuticals, Inc.

Coronavirus (COVID-19) Current Therapy Global Market Opportunities And Strategies To 2030: COVID-19 Growth And Change from The Business Research ...

Coronavirus (COVID-19) Current Therapy Global Market Report 2022

Published Date - Mar 2022
Report Code - TBR1058C

Including: 1) By Drug Type: Remdesivir; Hydroxychloroquine; Ritonavir; Lopinavir; Interferon Beta; Others
2) By Route Of Administration: Oral; Intravenous
3) By End User: Hospitals; Clinics; Research Institutes; Others
Covering: Moderna Therapeutics; Novavax; Bravovax; Ascletis Pharma; Altimmune; Clover Biopharmaceuticals; Inovio Pharmaceuticals inc.

Coronavirus (COVID-19) Current Therapy Global Market Report 2022 from The Business Research Company provides the strategists, marketers and ...

Coronavirus (COVID-19) Current Therapy Global Market Report 2021: COVID-19 Growth And Change To 2030

Published Date - Sep 2021
Report Code - TBR1058B

Including: 1) By Drug Type: Remdesivir; Hydroxychloroquine; Ritonavir; Lopinavir; Interferon Beta; Others
2) By End User: Hospitals; Clinics; Research Institutes; Others
Covering: Moderna Therapeutics; Novavax; Bravovax; Ascletis Pharma; Altimmune

Coronavirus (COVID-19) Current Therapy Global Market Report 2021: COVID-19 Growth And Change to 2030 from The Business Research Company provides the strategists, marketers and senior management with the critical ...

Coronavirus (COVID-19) Current Therapy Global Market Report 2020: COVID 19 Growth and Change

Published Date - Jul 2020
Report Code - TBR1058A

Including:

1) By Drug Type: Remdesivir; Hydroxychloroquine; Ritonavir; Lopinavir; Interferon Beta; Others
2) By End User: Hospitals; Clinics; Research Institutes; Others

Covering: Moderna Therapeutics; Novavax; Bravovax; Ascletis Pharma; Altimmune

Coronavirus (COVID-19) Current Therapy Global Market Report 2020: COVID 19 Growth and Change from The Business Research Company provides the strategists, marketers and senior management with the critical information they need ...